Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News NUCLIDIUM 84 million euros for radiopharmaceuticals 84 million euros for NUCLIDIUM. Copper-based radiopharmaceuticals receive strong funding.

Marc Nemitz 01.01.1970

News EvlaBio receives 21 million euros in seed funding Million-euro investment for biotech from Düsseldorf and Zurich. EvlaBio raises 21 million euros for the further development of an innovative drug for patients with chronic kidney disease and high cardiac risk.

Marc Nemitz 01.01.1970

News Cellugy receives 8.1 million euros to scale up sustainable microplastic alternative in cosmetic products With EcoFLEXY, the Danish biotech start-up Cellugy is developing a biodegradable solution to replace fossil ingredients in the cosmetics industry.

Marc Nemitz 01.01.1970

News Differential Bio secures €2 million pre-seed The Munich-based AI biotech start-up Differential Bio is emerging from stealth mode. The virtual scale-up platform aims to make bio-based production processes more efficient and scalable.

Marc Nemitz 01.01.1970

News Hubble Therapeutics closes USD 7.3 million Series A financing The funds will be used for the further clinical development of the gene therapy HUB-101, which focuses on rare eye diseases such as LCA16.

Marc Nemitz 01.01.1970

News Mycoprotein production - Kynda secures 3 million euro seed With the support of Enjoy Ventures, PHW Group and Clima Now, the start-up is scaling up its sustainable fermentation solution for food and animal feed production.

Marc Nemitz 01.01.1970

News InfectoPharm invests in AudioCure InfectoPharm joins AudioCure Pharma as a new investor. Together with MED-EL and High-Tech Gründerfonds, the development of AC102 is to be further advanced

Marc Nemitz 11.07.5260

News Bürkert Fluid Control Systems invests in Green Elephant Biotech The strategic partnership with the start-up aims to enable resource-saving bioreactors for the pharmaceutical industry.

Marc Nemitz 11.07.1762

News Phaeosynt secures 1.7 million euros seed for market entry With a successful financing round, Phaeosynt is ready for the next phase of growth. The biotech start-up focuses on vegan antibody technology for sustainable diagnostics.

Marc Nemitz 01.01.1970

Reports Germany leads the way in oncology start-ups Germany is one of the European leaders in cancer-related patents and start-ups. However, according to a new study by the EPO, scaling up remains a challenge.

Marc Nemitz 11.07.1169

1
2
3